Pregnancy and rheumatic diseases.
Pregnancy is an issue that should be discussed with all patients with rheumatic diseases who are in the reproductive age group. Infertility is rarely due to the disease but can be associated with cyclophosphamide therapy. Most rheumatic diseases that are well controlled prior to pregnancy do not deteriorate in pregnancy, providing that the patient continues with appropriate disease-modifying therapy. Some patients with inflammatory arthritis go in to remission during pregnancy. Patients with renal involvement may be at increased risk of disease flare. This needs to be distinguished from pre-eclampsia. Intrauterine growth restriction is more likely in patients with active systemic disease, hypertension, a history of thrombosis and renal involvement. Premature delivery may need to be planned to reduce the risks of stillbirth and can be associated with a variety of neonatal complications. Post-partum flare is common in all the rheumatic diseases.
Gayed
M
M
Department of Rheumatology, Division of Immunity and Infection (East Wing), The Medical School University of Birmingham, Birmingham B15 2TT, UK. p.c.gordon@bham.ac.uk
Gordon
C
C
D001327:Autoimmune Diseases / Q000150:complications / Q000175:diagnosis; D005260:Female; D005298:Fertility; D006801:Humans; D007112:Immunity, Maternally-Acquired; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis; D011256:Pregnancy Outcome; D011297:Prenatal Exposure Delayed Effects; D012216:Rheumatic Diseases / Q000150:complications* / Q000175:diagnosis